Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MIRA Pharmaceuticals, Inc. - Common Stock
(NQ:
MIRA
)
0.8400
-0.0100 (-1.18%)
Streaming Delayed Price
Updated: 3:30 PM EDT, Apr 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MIRA Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 20, 2023
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 20, 2023
Via
Benzinga
Why Is Depression Focused MIRA Pharmaceuticals Stock Trading Higher Today?
November 20, 2023
MIRA Pharmaceuticals Inc (NASDAQ: MIRA) announced a partnership with MIRALOGX, LLC, an intellectual property holding company
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Thursday's After-Market Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 23, 2023
Via
Benzinga
Why Biophytis Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
September 25, 2023
Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday.
Via
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 25, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
September 18, 2023
Via
Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 18, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 13, 2023
Via
Benzinga
Why Tenon Medical Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket
September 11, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 11, 2023
We're starting off the workweek right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 07, 2023
Via
Benzinga
Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
September 07, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 07, 2023
We're diving into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 30, 2023
Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning!
Via
InvestorPlace
MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
August 09, 2023
Via
ACCESSWIRE
Synthetic THC Researcher Mira Pharmaceuticals Debuts On Nasdaq
August 06, 2023
Mira Pharmaceuticals made its public debut on the Nasdaq this week. The company raised $8.9 million in its IPO, which it intends to use towards accelerating toxicology and clinical research of its...
Via
Talk Markets
Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO
August 03, 2023
Pre-clinical-stage biopharma company, MIRA Pharmaceuticals (NASDAQ: MIRA) launched its initial public offering Thursday and is trading $6.72 per share at the time of reporting.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.